التفاصيل البيبلوغرافية
| العنوان: |
Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients. |
| المؤلفون: |
Guerrero-Fernández de Alba, Inmaculada, Orlando, Valentina, Monetti, Valeria M., Mucherino, Sara, Gimeno-Miguel, Antonio, Vaccaro, Olga, Forjaz, Maria João, Poblador Plou, Beatriz, Prados-Torres, Alexandra, Riccardi, Gabriele, Menditto, Enrica |
| المصدر: |
Frontiers in Pharmacology; 11/30/2020, Vol. 11, pN.PAG-N.PAG, 1p |
| مصطلحات موضوعية: |
TYPE 2 diabetes, COMORBIDITY, DIABETES, OLDER patients, MEDICAL care, DISTRIBUTION costs |
| مصطلحات جغرافية: |
CAMPANIA (Italy) |
| مستخلص: |
Objectives: Little is known about the specific comorbidities contributing to higher costs in patients with type-2 diabetes mellitus (T2DM), particularly in older cases. We aimed to evaluate the prevalence, type, and cost of comorbidities occurring in older T2DM patients versus older non-T2DM patients, and the factors associated with high cost (HC) T2DM patients. Methods: Retrospective cohort study using information from the Campania Region healthcare database. People aged ≥65 years who received ≥2 prescriptions for antidiabetic drugs were identified as "T2DM patients." Comorbidities among T2DM and non-T2DM groups were assessed through the RxRiskV Index (modified version). T2DM individuals were classified according to the total cost distribution as HC or "non-high cost." Two sub-cohorts of HC T2DM patients were assessed: above 90th and 80th percentile of the total cost. Age- and sex-adjusted logistic regression models were created. Results: Among the T2DM cohort, concordant and discordant comorbidities occurred significantly more frequently than in the non-T2DM cohort. Total mean annual cost per T2DM patient due to comorbidities was €7,627 versus €4,401 per non-T2DM patient. Among T2DM patients identified as being above 90th and 80th percentiles of cost distribution, the total annual costs were >€19,577 and >€2,563, respectively. The hospitalization cost was higher for T2DM cases. Strongest predictors of being a HC T2DM patient were having ≥5 comorbidities and renal impairment. Conclusion: HC patients accrued >80% of the total comorbidities cost in older T2DM patients. Integrated care models, with holistic and patient-tailored foci, could achieve more effective T2DM care. [ABSTRACT FROM AUTHOR] |
|
Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder